A Phase 2, Open Label, Randomized, Active-Controlled Pilot Study MW-III vs Silver Sulfadiazine Second Degree Thermal Burns
Sponsored by Skingenix, Inc.
About this trial
Last updated 2 years ago
Study ID
MW-III-BURN-2-001
Status
Recruiting
Type
Interventional
Phase
Phase 2
Placebo
No
Accepting
18+ Years
All
Not accepting
Healthy Volunteers
Trial Timing
Ended a year ago
What is this trial about?
To compare MW-III to Silvadene® Cream 1% (Silver Sulfadiazine) with respect to "time to
healing" in second-degree thermal burns
What are the participation requirements?
Inclusion Criteria
1. Adults (≥18 years of age) on the day of signing the informed consent
2. Diagnosed with a single second-degree thermal burn
3. Burn occurrence ≤24 hours prior to study entry
4. Able and willing to give informed consent and comply with study procedures.
Exclusion Criteria
1. Patients with the co-existence of full thickness (third-degree) burn wound
2. Multiple second-degree thermal burns
3. Circumferential burns or burns deemed high risk for developing compartment syndrome
4. Target burn wound requiring surgical intervention, such as excision/grafting